Genpact Limited (NYSE:G) Shares Sold by PDS Planning Inc

PDS Planning Inc lowered its stake in Genpact Limited (NYSE:G) by 20.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,409 shares of the business services provider’s stock after selling 1,886 shares during the quarter. PDS Planning Inc’s holdings in Genpact were worth $318,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of G. SRH Advisors LLC acquired a new position in Genpact in the fourth quarter valued at about $26,000. Manchester Capital Management LLC acquired a new position in Genpact in the fourth quarter valued at about $38,000. Smartleaf Asset Management LLC lifted its position in Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock valued at $41,000 after buying an additional 783 shares during the last quarter. UMB Bank n.a. lifted its position in Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after buying an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp increased its stake in Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock worth $69,000 after purchasing an additional 453 shares during the period. Institutional investors and hedge funds own 96.03% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on G shares. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price target for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Needham & Company LLC boosted their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Finally, Mizuho boosted their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Genpact presently has a consensus rating of “Hold” and an average target price of $48.44.

Insider Activity at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by corporate insiders.

Genpact Stock Up 0.2 %

G stock opened at $50.47 on Wednesday. The company’s 50 day moving average price is $49.86 and its 200 day moving average price is $44.46. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76. The firm has a market capitalization of $8.87 billion, a price-to-earnings ratio of 17.77, a PEG ratio of 1.84 and a beta of 1.16.

Genpact (NYSE:G) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities research analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.35%. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. Genpact’s dividend payout ratio is 23.94%.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.